WESPAC Advisors LLC Invests $544,000 in Kenvue Inc. $KVUE

Key Points

• WESPAC Advisors LLC invested approximately $544,000 in Kenvue Inc. by acquiring 25,985 shares during the 2nd quarter, indicating growing institutional interest in the company.
• Kenvue announced a quarterly dividend of $0.2075 per share, marking an increase from the previous dividend, with an annualized yield of 5.1%.
• Analysts have mixed views on Kenvue, with one firm upgrading its rating to "strong-buy" while others have adjusted price targets, resulting in an average rating of "Hold" for the stock.

WESPAC Advisors LLC bought a new position in shares of Kenvue Inc. (NYSE:KVUE - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 25,985 shares of the company's stock, valued at approximately $544,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Pittenger & Anderson Inc. bought a new stake in Kenvue in the 1st quarter worth about $30,000. Trust Co. of Vermont grew its position in Kenvue by 266.8% in the 2nd quarter. Trust Co. of Vermont now owns 1,581 shares of the company's stock worth $33,000 after purchasing an additional 1,150 shares in the last quarter. TruNorth Capital Management LLC bought a new stake in Kenvue in the 1st quarter worth about $36,000. Truvestments Capital LLC bought a new stake in Kenvue in the 1st quarter worth about $37,000. Finally, Clal Insurance Enterprises Holdings Ltd grew its position in Kenvue by 378.5% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,627 shares of the company's stock worth $39,000 after purchasing an additional 1,287 shares in the last quarter. 97.64% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on KVUE shares. Rothschild Redb raised shares of Kenvue from a "hold" rating to a "strong-buy" rating in a research report on Friday, September 26th. UBS Group reduced their price objective on shares of Kenvue from $25.00 to $23.00 and set a "neutral" rating for the company in a research report on Thursday, July 17th. Evercore ISI reduced their price objective on shares of Kenvue from $23.00 to $18.00 and set an "in-line" rating for the company in a research report on Tuesday, September 23rd. Rothschild & Co Redburn raised shares of Kenvue from a "neutral" rating to a "buy" rating and reduced their target price for the company from $22.50 to $22.00 in a research report on Friday, September 26th. Finally, Canaccord Genuity Group reduced their target price on shares of Kenvue from $29.00 to $26.00 and set a "buy" rating for the company in a research report on Friday, August 8th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Kenvue currently has an average rating of "Hold" and a consensus target price of $22.46.

Kenvue Stock Up 3.3%

Kenvue stock opened at $16.21 on Wednesday. Kenvue Inc. has a twelve month low of $15.47 and a twelve month high of $25.17. The firm has a 50 day moving average price of $19.46 and a 200-day moving average price of $21.46. The company has a market capitalization of $31.10 billion, a P/E ratio of 21.90, a P/E/G ratio of 2.25 and a beta of 0.72. The company has a quick ratio of 0.68, a current ratio of 0.98 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, beating analysts' consensus estimates of $0.28 by $0.01. The firm had revenue of $3.84 billion during the quarter, compared to the consensus estimate of $3.94 billion. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. The company's revenue was down 4.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.32 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, equities analysts predict that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, August 27th. Investors of record on Wednesday, August 13th were paid a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a dividend yield of 5.1%. The ex-dividend date was Wednesday, August 13th. This is an increase from Kenvue's previous quarterly dividend of $0.21. Kenvue's dividend payout ratio is currently 112.16%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.